Portal Instruments
June 24, 2026
Theater 4
Type: Company Presentation
Focus Area:
Medical Devices
Portal Instruments is developing PRIME NEXUS, a reusable, computer-controlled auto-injector platform designed to deliver next-generation biologics that are too high-volume or viscous for conventional injection devices. By enabling reliable SQ delivery of therapies that would otherwise require IV infusion, Portal aims to help pharma bring advanced biologics closer to the patient's home. The company has initiated its first two co-development agreements with biopharma partners, providing early validation of the platform and commercial interest.
.jpg)
Company HQ City:
Cambridge
Company HQ State:
MA
Company HQ Country:
United States
Year Founded:
2014
Lead Product in Development:
PRIME NEXUS auto-injector
CEO
Patrick Anquetil, PhD, MBA
Development Phase of Lead Product
Phase II
When you expect your next catalyst update?
July 2027
What is your next catalyst (value inflection) update?
Initiate clinical study in Q3 2027 for drug/device combination product
Primary Speaker
)
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}